This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West

Attendee Deadline to Submit a Poster Abstract

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
February 27 - March 2, 2023San Diego Convention Center

Delivered as a Hybrid Event
February 27 - March 2, 2023,
San Diego Convention Center

Access ground breaking bioprocessing, manufacturing & supply chain strategies to revolutionize your cell, gene and CAR-T clinical and late stage programs.

Learn how industry leaders are driving the successful commercialization of these life changing products

Access Key Industry Updates & Scientific Insights Across the Cell & Gene Therapy Spectrum

Monitoring Quality Across the Process - Process and Automated Analytics for Cell and Gene Therapies

  • Developing potency strategies for gene therapy products
  • Augmenting Automated Analytics for Cell & Gene Therapy Manufacture
  • Analytical tools for a fast and robust commercial vector process
  • Evolution in gene transfer technology and its potential role in saving money longer term

Technologies and Novel Platforms for Efficient Upstream and Downstream Processes

  • Closed, automated and controlled upstream processing for iPSC-derived cell therapies
  • Upstream Raw Material Variation Monitoring and Control Strategies

Strategies for Optimized Process Development

  • Manufacturing Process & Product Development Efforts
  • Process Validation and CPV for Cell and Gene Therapy
  • Creation of Fit-for Purpose Devices and an All-in-One Automated Platform 

Translation from Small to Commercial Scale Manufacturing

  • Large scale gene modification
  • Strategizing an economically viable manufacturing journey
  • Instrumentation and mechanisms to drive efficient therapies

Critical Challenges in Effective Scalability

  • Reinvention and Optimization of Vector Production
  • New manufacturing models for autologous cell therapies

Manufacturing Feasibility: Ensuring a Financially Viable Strategy

  • Gene therapy productivity: Viral vector supply and demand
  • Feedback from the Industry Alliance Partnership (IAP) & CIRM Partnership and Commercialization Opportunities
  • PANEL: CMO landscapes for new product initiatives: Novel outsourcing models

Single-Use Technologies for Cell and Gene Therapies

This 1-day hands-on course (held on August 10, 2020) provides an Introduction to Single-Use Technologies and the specific attributes and quality needs when implementing Single-Use Technologies in Cell and Gene Therapy Manufacturing. Course participants will experience the latest Single-Use products first hand during the lab portion of the course.  

Course Instructor: James Dean Vogel, P.E., Founder of The BioProcess Institute

Connect with Global Scientists and Decision Makers Working Across Cell & Gene Therapy

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

(Companies A-L) Contact Jennifer Wickett: | +1-857-504-6694 

(Companies M-Z) Contact Blake Shuka: | +1-857-504-6684